Nephrology News
Lower IV Iron Dosing in Anemic Dialysis Patients May Be More Effective
To support ESA therapy, IV iron at doses below 300 mg/month may be most effective for the average hemodialysis patient, according to an observational study.
By accepting you will be accessing a service provided by a third-party external to https://galencarepartners.com/